Archives

by in
Entry Author Date Location
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target 01/03/13 San Diego
SD Biotech Roundup: Life Technologies, KFx Medical, Shire, & More 06/15/12 San Diego
What Are the Hottest Targets in Biotech Today? 04/23/12 National
San Diego’s InflammaGen Advances Therapy to Mitigate Effects of Shock 03/12/12 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
San Diego’s Leading Ventures Takes on Commercialization of Bioengineering Breakthroughs 02/08/11 San Diego
Xoma Nabs $35M Upfront Deal 01/04/11 San Francisco
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation 11/16/10 San Francisco
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Alder Reduces Anemia in Cancer Study 06/06/10 Seattle
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
How Internet Pioneer Larry Smarr Lost 20 Pounds by Becoming a “Quantified Self” 05/12/10 San Diego
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation 04/21/10 Boston
Ascent Changes to Anchor 03/30/10 Boston
Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model 01/29/10 Boston
Omeros Moves Closer To IPO, Sets Price Goal 09/16/09 Seattle
Lankau New CEO at Logical 05/11/09 Boston
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting 03/17/09 Seattle
Calistoga Reunites Icos Execs To Pursue Cancer, Inflammation Drugs 03/11/09 Seattle
Meritage Starts Study of Inflammatory Disease 01/22/09 San Diego
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs 01/06/09 Seattle
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes 12/18/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge 08/14/08 Boston
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010 08/05/08 Seattle
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.